413 related articles for article (PubMed ID: 36551041)
1. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
Zhang J; Chen Z; Chen H; Deng Y; Li S; Jin L
Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551041
[TBL] [Abstract][Full Text] [Related]
2. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.
Khezri MR; Yousefi K; Zolbanin NM; Ghasemnejad-Berenji M
Mol Neurobiol; 2022 Mar; 59(3):1589-1603. PubMed ID: 35001356
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
[TBL] [Abstract][Full Text] [Related]
6. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.
Rezaee D; Saadatpour F; Akbari N; Zoghi A; Najafi S; Beyranvand P; Zamani-Rarani F; Rashidi MA; Bagheri-Mohammadi S; Bakhtiari M
Ageing Res Rev; 2023 Dec; 92():102090. PubMed ID: 37832609
[TBL] [Abstract][Full Text] [Related]
7. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases.
Sarkar S; Roy D; Chatterjee B; Ghosh R
Metabolomics; 2024 Mar; 20(2):37. PubMed ID: 38459207
[TBL] [Abstract][Full Text] [Related]
8. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
9. [Research Progress of microRNA-7/124/155 in Parkinson's Disease].
Chen T; Chen H; Yan WH; Zhu MY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):484-492. PubMed ID: 37407538
[TBL] [Abstract][Full Text] [Related]
10. Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.
Noelker C; Hampel H; Dodel R
Mol Diagn Ther; 2011 Apr; 15(2):83-102. PubMed ID: 21623645
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for neurodegenerative diseases.
Hansson O
Nat Med; 2021 Jun; 27(6):954-963. PubMed ID: 34083813
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
Qiu L; Zhang W; Tan EK; Zeng L
ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
[TBL] [Abstract][Full Text] [Related]
13. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
Roy B; Lee E; Li T; Rampersaud M
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
[TBL] [Abstract][Full Text] [Related]
14. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
15. Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.
Wang Y; Yang Z; Le W
Neurosci Bull; 2017 Oct; 33(5):543-551. PubMed ID: 28762215
[TBL] [Abstract][Full Text] [Related]
16. Eye movements in neurodegenerative diseases.
MacAskill MR; Anderson TJ
Curr Opin Neurol; 2016 Feb; 29(1):61-8. PubMed ID: 26641817
[TBL] [Abstract][Full Text] [Related]
17. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
[TBL] [Abstract][Full Text] [Related]
18. A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
Piscopo P; Bellenghi M; Manzini V; Crestini A; Pontecorvi G; Corbo M; Ortona E; Carè A; Confaloni A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922607
[TBL] [Abstract][Full Text] [Related]
19. Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.
Karaboğa MNS; Sezgintürk MK
J Pharm Biomed Anal; 2022 Feb; 209():114479. PubMed ID: 34861607
[TBL] [Abstract][Full Text] [Related]
20. The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.
Danborg PB; Simonsen AH; Waldemar G; Heegaard NH
Biomarkers; 2014 Jun; 19(4):259-68. PubMed ID: 24678935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
